+ 1.86
+ 0.55%

Curaleaf International's Adven GmbH Launches Medical Cannabis Products In Germany

May 12, 2021 10:06 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Curaleaf International's Adven GmbH Launches Medical Cannabis Products In Germany

Curaleaf International's subsidiary, Adven GmbH, recently introduced its medical cannabis products in Germany, Europe's largest medical cannabis market.

Massacussets-based Curaleaf Holdings, Inc. (CSE:CURA) (OTCQX:CURLF) purchased EMMAC Life Sciences – now operating as Curaleaf International – in April in a $310 million deal.             

To further expand its footprint in Europe, Curaleaf has created Curaleaf International Holdings Limited on the island of Guernsey.

Initial Adven GmbH's offering will include a high THC oil product. Over the next 12 months, the company intends to boost its product portfolio with additional THC and CBD formulations in oil and flower formats.

Julian Vaterrodt, managing director of Adven GmbH, said the demand for "high-quality, consistent and reliable European natural alternatives to help manage a wide range of complaints" has increased among both patients and practitioners in Germany.

"We focus on providing a consistent supply of high-quality European medical cannabis and cutting-edge digital technologies to improve the patient and healthcare professional experience," Vaterrodt added.

Curaleaf International CEO, Antonio Costanzo, said he is pleased to launch medical cannabis products in Germany and establish the company throughout the European Union. 

"Curaleaf International's European supply chain, from cultivation to product research and development and EU-GMP manufacturing processes across Europe, means we are able to guarantee a consistency of product and price to clinicians and patients in need of the highest quality medical cannabis," Costanzo said.

Constanzo was appointed to help Curaleaf's European branch in April.

Photo by Esteban Lopez on Unsplash

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to our YouTube channel.

Related Articles

The Week In Cannabis: Federal Research Bill, George Lopez, Brazil, Morocco, Columbia Care And More

As we near the end of the first half of 2021, we can see cannabis stocks traded mostly up by double digits, with the Amplify Seymour Cannabis ETF (NYSE: CNBS) delivering gains of more than 50% year-to-date. This week, however, stocks posted mixed performances. read more

The Week In Cannabis: Earnings, Financings, M&A, Cookies U, DEA, DJ Khaled, And More

In an earnings-heavy week, cannabis stocks experienced considerable volatility. read more

Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week

Welcome to the Cannabis Countdown, the Legal Marijuana Industry’s Number One Curated Weekly News Recap. read more

The Week In Cannabis: Trulieve's $2.1B Acquisition, New ETF, Earnings, Federal Legalization And More

In a week of big M&A news and mixed earnings reports, cannabis stocks traded mostly down. read more